Inventor · disambiguated record
Lyndi Rice
Also filed as: RICE LYNDI · RICE LYNDI M
4 granted patents·2 pending applications·2 citations·filing 2013–2018
59Inventor score
Top patents by PatentIndex Score
6 records- 0160US9657349B2PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transitionRICE LYNDI·Filed 2014·Granted May 23, 2017·2 cites·10 claims
- 0250US10167472B2PME-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transitionMEDICAL DIAGNOSTIC LABORATORIES L L C·Filed 2017·Granted Jan 1, 2019·0 cites·4 claims
- 0350US9139829B2SiRNA targeting ETS1 and ELK1 and method of using same in the inhibition of CIP2A gene in cancer treatmentMEDICAL DIAGNOSTIC LAB LLC·Filed 2013·Granted Sep 22, 2015·0 cites·8 claims
- 0442US9663789B2PME-1 as a biomarker to predict and diagnose endometrial and breast cancer and gene silencing of PME-1 to inhibit epithelial to mesenchymal transitionRICE LYNDI M·Filed 2014·Granted May 30, 2017·0 cites·5 claims
- 0535US2020190592A1Pme-1 as a biomarker to predict and diagnose an increased risk of endometrial cancer and gene silencing of pme-1 to inhibit epithelial to mesenchymal transitionMEDICAL DIAGNOSTIC LABORATORIES L L C·Filed 2018·Application pending·0 cites
- 0628US2016082034A1SiRNA TARGETING ETS1 AND ELK1 AND METHOD OF USING SAME IN THE INHIBITION OF CIP2A GENE IN CANCER TREATMENTRICE LYNDI M·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lyndi Rice files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →